Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Establishment and Characterization of a New Cell Line, FPS-1, Derived from Human Undifferentiated Pleomorphic Sarcoma, Overexpressing Epidermal Growth Factor Receptor and Cyclooxygenase-2

MICHIYUKI HAKOZAKI, HIROSHI HOJO, MICHIKO SATO, TAKAHIRO TAJINO, HITOSHI YAMADA, SHINICHI KIKUCHI and MASAFUMI ABE
Anticancer Research September 2006, 26 (5A) 3393-3401;
MICHIYUKI HAKOZAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paco{at}fmu.ac.jp
HIROSHI HOJO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHIKO SATO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAHIRO TAJINO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HITOSHI YAMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINICHI KIKUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAFUMI ABE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Undifferentiated pleomorphic sarcoma (UPS) is among the most common soft tissue sarcomas in adults. In order to improve its aggressive course or prognosis and establish new therapeutic methods, molecular genetic and biological characterizations of UPS are required. Materials and Methods: A new human UPS cell line (FPS-1) was established from UPS of the upper arm of a 79-year-old man. The cell line has been maintained for over 14 months with more than 60 passages. FPS-1 cells were characterized using molecular biological methods. Results: FPS-1 cells showed the same morphological and immunophenotypical characteristics as the primary tumor. Cytogenetic and molecular analyses revealed a nonsense mutation in exon 6 of the p53 gene. Epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) were expressed in FPS-1 cells. Conclusion: FPS-1 cells might be useful for investigating biological behavior and developing new molecular targeting antitumor drugs for UPS with EGFR or COX-2 expression.

  • Undifferentiated pleomorphic sarcoma
  • malignant fibrous histiocytoma (MFH)
  • FPS-1 cell line
  • p53 gene
  • epidermal growth factor receptor (EGFR)
  • cyclooxygenase-2 (COX-2)
  • sarcoma

Footnotes

  • Received May 23, 2006.
  • Accepted July 12, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 5A
September-October 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Establishment and Characterization of a New Cell Line, FPS-1, Derived from Human Undifferentiated Pleomorphic Sarcoma, Overexpressing Epidermal Growth Factor Receptor and Cyclooxygenase-2
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Establishment and Characterization of a New Cell Line, FPS-1, Derived from Human Undifferentiated Pleomorphic Sarcoma, Overexpressing Epidermal Growth Factor Receptor and Cyclooxygenase-2
MICHIYUKI HAKOZAKI, HIROSHI HOJO, MICHIKO SATO, TAKAHIRO TAJINO, HITOSHI YAMADA, SHINICHI KIKUCHI, MASAFUMI ABE
Anticancer Research Sep 2006, 26 (5A) 3393-3401;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Establishment and Characterization of a New Cell Line, FPS-1, Derived from Human Undifferentiated Pleomorphic Sarcoma, Overexpressing Epidermal Growth Factor Receptor and Cyclooxygenase-2
MICHIYUKI HAKOZAKI, HIROSHI HOJO, MICHIKO SATO, TAKAHIRO TAJINO, HITOSHI YAMADA, SHINICHI KIKUCHI, MASAFUMI ABE
Anticancer Research Sep 2006, 26 (5A) 3393-3401;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
  • Google Scholar

More in this TOC Section

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire